New Testing Method for African Swine Fever
A promising tool to quickly detect ASF in pigs is being developed.
Sekhar Kambakam, Julia Thomas, Suelee Robbe-Austerman, Karthik Shanmuganatham, Rachel Palinski
― 6 min read
Table of Contents
African Swine Fever (ASF) is a viral disease that affects pigs, both domestic and wild. This illness is caused by a virus known as the African Swine Fever Virus (ASFV). It belongs to a group of viruses that are known for their complex structure. ASFV has a large amount of genetic material, specifically double-stranded DNA, and it can produce over 160 different proteins that help it function.
ASF is notorious for being highly contagious. This means that if one pig gets infected, it can quickly spread to others, creating significant problems for pig farmers. ASFV can be passed from pig to pig through direct contact, but it can also survive outside of the pigs for a long time. It can linger in the environment, in feed, on equipment, or even on clothes. Because of this, the virus can cause serious worries for the pork industry globally.
Infected pigs can show a variety of symptoms. They often develop a high fever and can become lethargic, lose their appetite, vomit, have diarrhea, and even suffer from bleeding and breathing difficulties. In cases where the infection is severe, pigs can die quickly, sometimes within a week, and the death rate can be as high as 100%.
Origins and Spread of ASF
ASF is believed to have started in sub-Saharan Africa, where the virus is still present among the local pig populations. Over the years, outbreaks have occurred in Europe and the Americas, though many of these were eventually controlled.
A significant outbreak happened in Georgia in 2007, leading to the virus becoming widespread among wild boar populations in Eastern Europe. For more than a decade, ASF remained fairly contained until biosecurity measures were breached, allowing it to spread rapidly into China in 2018. This outbreak had dramatic effects, causing a collapse in the country’s pig farming industry.
In 2021, the virus was detected on the Caribbean island of Hispaniola, and this outbreak is still ongoing, which raises concerns for countries like the United States. To combat this threat, the U.S. has ramped up its efforts to monitor and control ASF. They have implemented strict measures to prevent the movement of pork and related products from affected territories, in hopes of protecting their domestic pig population.
The Need for Effective Diagnosis
Given the serious impact of ASF, quick and accurate detection is vital. Traditional methods like QPCR (which stands for quantitative Polymerase Chain Reaction) are currently the gold standard for diagnosing ASFV. However, qPCR requires pricey equipment, special training, and specific lab setups, making it impractical for use in areas with limited resources.
Alternative methods like RPA (Recombinase Polymerase Amplification) and LAMP (Loop-Mediated Isothermal Amplification) have been developed but do not match the accuracy of qPCR. This is akin to trying to catch a fast animal with a slower net. The challenge lies in creating tests that are as good as qPCR, but simple enough for anyone to use, even in remote areas.
CRISPR Technology
An Innovative Approach:Recently, a new technique called CRISPR has made waves in many fields, including genetic engineering and medicine. This technology has the potential to be adapted for diagnosing diseases, including ASF.
By combining CRISPR with RPA, researchers are trying to develop faster and more straightforward tests that can be used right at the site where pigs are kept. This dual approach could potentially help farmers quickly identify infections and prevent larger outbreaks.
Developing a New Testing Method
In this research, scientists focused on creating a new test for ASFV by using RPA paired with CRISPR technology. First, they selected small pieces of RNA designed to target ASFV. This involved testing how effective these pieces were at recognizing the virus.
After confirming that the new test could identify ASFV accurately, they ensured that it worked well with various samples, from blood swabs to other biological materials. The new method aimed to provide results that matched those obtained through traditional qPCR testing, thus confirming its reliability.
How the New Test Works
The developed test is a simple two-step process. In the first step, RPA amplifies the virus’s genetic material if it's present in the sample. This step is carried out at a constant temperature, which makes it easier to manage.
Once the genetic material is amplified, CRISPR comes into play. The CRISPR system then recognizes and tags the amplified virus material and gives off a fluorescent signal. If the test works, the test area lights up, similar to the way a light bulb turns on when you flip the switch. This visual cue is especially useful, as it allows for quick checks without needing complex lab setups.
Testing the New Method
To ensure the new test works correctly, researchers conducted extensive trials. They prepared positive control samples containing ASFV DNA and tested these alongside samples from other viruses to confirm that the new method was not mistakenly identifying other viral infections as ASF.
The researchers also assessed how well the method performed under different conditions, including using various sample types that pigs might be tested in. They even added known concentrations of ASFV DNA to see if the test could pick it up reliably, which it did.
Evaluating Effectiveness
In these trials, the new method demonstrated solid performance. The test could accurately identify ASFV in both controlled conditions and real samples taken from pigs suspected of being infected. The results showed an impressive level of reliability, matching qPCR's findings, and highlighting how useful this method could be in the field.
Why This Matters
The development of this new test is crucial because it provides an essential tool for farmers and veterinarians. In the event of an ASF outbreak, a rapid and reliable test can help in early detection and control. Quick diagnosis means quicker action can be taken to prevent the spread of the virus.
This innovation can be especially beneficial in areas where resources and access to laboratory facilities are limited. By empowering those on the front lines of pig farming, this test could help safeguard the industry from the devastating effects of ASF.
Conclusion
In summary, the rise of ASF poses a significant challenge to pig farming globally, affecting food supply and economic stability. The development of a simple, effective testing method that combines RPA and CRISPR could change the way we approach this disease.
With a fast and accurate tool to diagnose ASF, we could see a decrease in outbreaks and reduced risk to the pig populations. Sometimes, it takes a bit of creativity and innovation—like mixing science with a touch of humor—to overcome challenges. Scientists are continually working to bend the curve of disease spread, making the world a safer place for our four-legged friends and the farmers that care for them.
Original Source
Title: Rapid identification of African swine fever virus in diagnostic samples using CRISPR-Cas
Abstract: African Swine Fever Virus (ASFV) is a high consequence, highly transmissible pathogen affecting swine causing African Swine Fever (ASF), a devastating disease, with high mortality rates in naive populations. Due to the likelihood of significant economic impacts associated with an ASF outbreak, considerable resources have been allocated in the United States (U.S.) to safeguard the swine industry against this threat. Ongoing outbreaks of ASF in the Dominican Republic and Haiti further threaten U.S. swine due to their proximity and involvement in movement to and from North America. While surveillance programs are ongoing, there are limited point-of-care (POC) tests available during outbreaks that maintain the sensitivity and specificity standards of laboratory testing (e.g., qPCR). However, the recently developed CRISPR-Cas testing systems may provide comparable high-quality results. In a CRISPR-based diagnostic assay, CRISPR effectors can be programmed with CRISPR-RNA (crRNA) to target specific DNA or RNA. Upon target binding, the Cas enzyme undergoes collateral cleavage of nearby fluorescently quenched reporter molecules (ssDNA or ssRNA), which can be detected under blue light or a fluorescence microplate reader. Furthermore, this tool is rapid, simple, cost-effective and can be performed with inexpensive equipment. For these reasons, we sought to develop a low-cost visual detection method for ASFV by employing the recombinase polymerase amplification (RPA)-dependent CRISPR-Cas12a technique that can be utilized in the field as a point-of-care-assay. Our CRISPR-Cas12a assay demonstrated comparable sensitivity and specificity to qPCR, both visually and when quantified using a fluorescent reader. In whole blood samples from ASFV-suspect or ASFV-negative cases, the CRISPR assay achieved a sensitivity of 98.3% (102 DNA copies) and a specificity of 100%. Finally, an assessment of the reaction time constraints indicated that results can be visualized in as little as seven minutes with a peak fluorescence at 40 min (RPA and CRISPR steps). The results of this feasibility assay validation allow for the rapid development of sensitive and specific POC tests that may be used for outbreak response in the future.
Authors: Sekhar Kambakam, Julia Thomas, Suelee Robbe-Austerman, Karthik Shanmuganatham, Rachel Palinski
Last Update: 2024-12-30 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.27.630508
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.27.630508.full.pdf
Licence: https://creativecommons.org/publicdomain/zero/1.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.